The city of Springfield, Illinois, currently has 1 active clinical trials seeking participants for Type 1 Diabetes research studies.
A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight
Recruiting
The main purpose of this study is to find out how well and how safely tirzepatide works in adults who have type 1 diabetes and obesity or overweight. Participation in the study will last about 49 weeks.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/25/2025
Locations: Southern Illinois University School of Medicine, Springfield, Illinois
Conditions: Type 1 Diabetes, Obesity, Overweight